Correlation Engine 2.0
Clear Search sequence regions

  • adult (1)
  • glia (1)
  • growth factors (1)
  • human (5)
  • injuries (1)
  • neurotrophin (1)
  • NGF (13)
  • Nogo Proteins (2)
  • optic nerve (7)
  • p75NTR (3)
  • rats (1)
  • rats long- evans (1)
  • retina (3)
  • Rock2 (1)
  • segment (1)
  • signals (1)
  • Sizes of these terms reflect their relevance to your search.

    Retinal ganglion cell (RGC) degeneration occurs within 2 weeks following optic nerve crush (ONC) as a consequence of reduced retro-transport of growth factors including nerve growth factor (NGF). The hypothesis that intravitreal (ivt) and eye drop (ed) administration of recombinant human NGF (rhNGF) might counteract ONC in adult rats is explored in this study. We found that both ivt- and ed-rhNGF reduced RGC loss and stimulated axonal regrowth. Chiefly, survival and regenerative effects of rhNGF were associated with a reduction of cells co-expressing Nogo-A/p75NTR at crush site borders, which contribute to glia scar formation following nerve injury, and induce further degeneration. We also found that ocular application of rhNGF reduced p75NTR and proNGF and enhanced phosphorylation of TrkA and its intracellular signals at retina level. Nogo-R and Rock2 expression was also normalized by ed-rhNGF treatment in both ONC and contralateral retina. Our findings that ocular applied NGF reaches and exerts biological actions on posterior segment of the eye give a further insight into the neurotrophin diffusion/transport through eye structures and/or their trafficking in optic nerve. In addition, the use of a highly purified NGF form in injury condition in which proNGF/p75NTR binding is favored indicates that increased availability of mature NGF restores the balance between TrkA and p75NGF, thus resulting in RGC survival and axonal growth. In conclusion, ocular applied NGF is confirmed as a good experimental paradigm to study mechanisms of neurodegeneration and regeneration, disclose biomarkers, and time windows for efficacy treatment following cell or nerve injury.


    Louise A Mesentier-Louro, Pamela Rosso, Valentina Carito, Rosalia Mendez-Otero, Marcelo F Santiago, Paolo Rama, Alessandro Lambiase, Paola Tirassa. Nerve Growth Factor Role on Retinal Ganglion Cell Survival and Axon Regrowth: Effects of Ocular Administration in Experimental Model of Optic Nerve Injury. Molecular neurobiology. 2019 Feb;56(2):1056-1069

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 29869196

    View Full Text